Repligen
RGEN
#2039
Rank
A$14.10 B
Marketcap
A$250.53
Share price
-0.46%
Change (1 day)
8.10%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$1.27 Billion

According to Repligen 's latest financial reports the company's total liabilities are A$1.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$1.37 B8.35%
2023-12-31A$1.27 B39.37%
2022-12-31A$0.91 B8.74%
2021-12-31A$0.83 B72.62%
2020-12-31A$0.48 B-0.01%
2019-12-31A$0.48 B115.31%
2018-12-31A$0.22 B15.98%
2017-12-31A$0.19 B16.78%
2016-12-31A$0.16 B416.95%
2015-12-31A$32.24 M59.34%
2014-12-31A$20.23 M22.3%
2013-12-31A$16.54 M33.44%
2012-12-31A$12.39 M
2011-03-31A$5.03 M-12.46%
2010-03-31A$5.75 M-13.12%
2009-03-31A$6.62 M28.94%
2008-03-31A$5.13 M17.36%
2007-03-31A$4.37 M-2.4%
2006-03-31A$4.48 M4.49%
2005-03-31A$4.29 M31.98%
2004-03-31A$3.25 M-12.53%
2003-03-31A$3.71 M-25.6%
2002-03-31A$4.99 M92.2%
2001-03-31A$2.6 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novavax
NVAX
A$2.02 B 59.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.35 B 85.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.90 B 50.14%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$165.07 B 12,892.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$78.39 B 6,069.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$118.32 B 9,213.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$174.77 B 13,655.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.84 B-33.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.12 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
A$6.14 B 383.33%๐Ÿ‡บ๐Ÿ‡ธ USA